BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18193184)

  • 41. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
    Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
    Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer.
    Fujii T; Shimada K; Tatsumi Y; Fujimoto K; Konishi N
    Biochem Biophys Res Commun; 2015 Jan; 456(1):183-9. PubMed ID: 25462564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
    Jopling CL; Norman KL; Sarnow P
    Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner.
    Ma N; Wang X; Qiao Y; Li F; Hui Y; Zou C; Jin J; Lv G; Peng Y; Wang L; Huang H; Zhou L; Zheng X; Gao X
    Mol Cell Endocrinol; 2011 Feb; 333(1):96-101. PubMed ID: 21146586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgene-like animal models using intronic microRNAs.
    Lin SL; Chang SJ; Ying SY
    Methods Mol Biol; 2006; 342():321-34. PubMed ID: 16957386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-directed cleavage of HOXB8 mRNA.
    Yekta S; Shih IH; Bartel DP
    Science; 2004 Apr; 304(5670):594-6. PubMed ID: 15105502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intron-mediated RNA interference, intronic microRNAs, and applications.
    Ying SY; Chang CP; Lin SL
    Methods Mol Biol; 2010; 629():205-37. PubMed ID: 20387152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
    Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
    J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping genetic variability in mature miRNAs and miRNA binding sites in prostate cancer.
    Lee B; Li JL; Marchica J; Mercola M; Patel V; Perera RJ
    J Hum Genet; 2021 Nov; 66(11):1127-1137. PubMed ID: 34099864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-497 suppresses proliferation and induces apoptosis in prostate cancer cells.
    Wang L; Li B; Li L; Wang T
    Asian Pac J Cancer Prev; 2013; 14(6):3499-502. PubMed ID: 23886135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-634 is a Pol III-dependent intronic microRNA regulating alternative-polyadenylated isoforms of its host gene PRKCA.
    Paraboschi EM; Cardamone G; Rimoldi V; Duga S; SoldĂ  G; Asselta R
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1046-1056. PubMed ID: 28212793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An intronic microRNA silences genes that are functionally antagonistic to its host gene.
    Barik S
    Nucleic Acids Res; 2008 Sep; 36(16):5232-41. PubMed ID: 18684991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNAs and prostate cancer.
    Pang Y; Young CY; Yuan H
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase.
    Kos A; Olde Loohuis NF; Wieczorek ML; Glennon JC; Martens GJ; Kolk SM; Aschrafi A
    PLoS One; 2012; 7(2):e31022. PubMed ID: 22363537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance.
    El Gazzar M; McCall CE
    J Biol Chem; 2010 Jul; 285(27):20940-51. PubMed ID: 20435889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells.
    Niespolo C; Johnston JM; Deshmukh SR; Satam S; Shologu Z; Villacanas O; Sudbery IM; Wilson HL; Kiss-Toth E
    Front Immunol; 2020; 11():574046. PubMed ID: 33329538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-126 and miR-126*: new players in cancer.
    Meister J; Schmidt MHH
    ScientificWorldJournal; 2010 Oct; 10():2090-100. PubMed ID: 20953557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.
    Saito Y; Friedman JM; Chihara Y; Egger G; Chuang JC; Liang G
    Biochem Biophys Res Commun; 2009 Feb; 379(3):726-31. PubMed ID: 19116145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The regulation of HAS3 by miR-10b and miR-29a in neuroendocrine transdifferentiated LNCaP prostate cancer cells.
    Czyrnik ED; Wiesehöfer M; Dankert JT; Wennemuth G
    Biochem Biophys Res Commun; 2020 Mar; 523(3):713-718. PubMed ID: 31948751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.
    Zhu N; Zhang D; Xie H; Zhou Z; Chen H; Hu T; Bai Y; Shen Y; Yuan W; Jing Q; Qin Y
    Mol Cell Biochem; 2011 May; 351(1-2):157-64. PubMed ID: 21249429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.